Suxamethonium-induced rhabdomyolysis in a healthy middle-aged man

Acta Anaesthesiologica Belgica

Volumn 51, Issue 1, 2000, Pages 51-53

  Le Puura, A I E ^b   Koivisto, P ^b   Annila, Päivi ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NONE

Author keywords

Complications; D NA testing; Hyperthermia; Malignant; Neuromuscular relaxants; Rhabdomyolysis; Suxamethonium

Indexed keywords

BICARBONATE; HALOTHANE; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; SUXAMETHONIUM; THIOPENTAL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; GENE MUTATION; GENERAL ANESTHESIA; GENETIC ANALYSIS; HUMAN; MALE; MALIGNANT HYPERTHERMIA; MUSCULAR DYSTROPHY; RHABDOMYOLYSIS;

ADULT; CREATINE KINASE; HUMANS; MALE; MALIGNANT HYPERTHERMIA; MUSCULAR DYSTROPHIES; NEUROMUSCULAR DEPOLARIZING AGENTS; PALATE, SOFT; PHARYNX; RHABDOMYOLYSIS; SLEEP APNEA SYNDROMES; SUCCINYLCHOLINE; UVULA;

EID: 0034057574     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Breucking E., Mortier W., Anaesthesia in neuromuscular diseases, ACTA ANaesth. BELG., 41, 127-32, 1990.
2. Brumback R. A., Feeback D. L., Leech R. W., Rhabdomyolysis in childhood. A primer on normal muscle function and selected metabolic myopathies characterized by disordered energy production, PEDIATR. CLIN. NAM., 39, 821-858, 1992.
3. Bush A., Dubowitz V., Fatal rhabdomyolysis complicating general anaesthesia in a child with Becker muscular dystrophy, NEUROMUSCULAR DISORD., 1, 201-204, 1991.
4. Farrell P. T., Anaesthesia-induced rhabdomyolysis causing cardiac arrest : Case report and review of anaesthesia and the dystrophinopathies, ANESTH. INTENS. CARE, 22, 597-601, 1994.
5. Fierobe L., Nivoche Y., Mantz J., et al., Perioperative severe rhabdomyolysis revealing susceptibility to malignant hyperthermia, ANESTHESIOLOGY, 88, 263-5, 1998.
6. Friedman S., Thomas B., Gatti M., Simon G., Paskin S., Probable succinylcholineinduced rhabdomyolysis in a male athlete, ANESTH. ANALG., 81, 422-3, 1995.
7. Fujii J., Otsu K., Zorzato F., et al., Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia, SCIENCE, 253, 448-51, 1991.
8. Harwood T. N., Nelson T. E., Massive postoperative rhabdomyolysis after uneventful surgery : A case report of subclinical malignant hyperthermia, ANESTHESIOLOGY, 88, 265-8, 1998.
9. Iles D. E., Lehmann-Horn F., Scherer S. W., et al., Localization of the gene encoding the alpha-2/delta-sub-units of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families, HUMAN MOL. GENET., 3, 969-75, 1994.
10. Larach M. G, Localio A. R, Allen G. C., et al., A clinical grading scale to predict malignant hyperthermia susceptibility, ANESTHESIOLOGY, 80, 771-9, 1994.
11. Lee S. C., Abe T., Sato T., Rhabdomyolysis and acute renal failure following use of succinylcholine and enflurane : report of a case. J. ORAL MAXIL. SURG., 47, 71-5, 1989.
12. Levit R. C., Olckers A., Meyers S., et al., Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to hitman chromosome 17q., GENOMICS, 14, 562-66, 1992.
13. Manning B. M., Quane K. A., Ording H., et al., Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia : genotype-phenotype correlation. AM. J. HUM. GENET., 62, 599-609, 1998.
14. Morocco P. A., Atraumatic rhabdomyolysis in a 20-year-old body-builder, J. EMERG. NURS., 17, 370-2, 1991.
15. Pedrozzi N. E., Ramelli G. P., Tomasetti R., Nobile-Buetti L., Bianchetti G. M., Rhabdomyolysis and anesthesia : A report of two cases and review of the litterature, PEDIATR. NEUROL., 15, 254-7, 1996.
16. Robinson R. E., Monnier N., Wolz W., et al., A genome wide search for susceptibility loci in three European malignant hyperthermia pedigrees, HUM. MOL. GENET., 6, 953-61, 1997.
17. Rosenberg A. D., Neuwirth M. G., Kagen E. J., et al., Intraoperative rhabdomyolysis in an patient receiving pravastatin, a 3-hydroxy-3- methylglutaryl coenzyme A (HMG CoA) reductase inhibitor, ANESTH. ANALG., 81, 1089-91, 1995.
18. Rubiano R., Chang J.-E., Carroll J., Sonbolian N., Larson C. E., Acute rhabdomyolysis following halothane anaesthesia without succinylcholine, ANESTHESIOLOGY, 67, 856-871, 1987.
19. Sudbrak R., Procaccio V., Klausnitzer M., et al., Mapping of a further malignant hyperthermiasusceptibilitylocusiochromosome 3q 13.1, AM. J HUM. GENET., 56, 684-91, 1995.
20. Tammisto T., Airaksinen M., Increase of creatine kinase activity in serum as a sign of muscular injury caused by intermittently administered suxamethonium during halothane anaesthesia, BR. J. ANNESTH., 38, 510-5, 1966.
21. Tang T. T., Oechler H. W., Siker A. D., Fraciosi R. A., Anaesthesia-induced rhabdomyolysis in infants with unsuspected Duchenne dystrophy, ACTA PAEDIATR., 81, 716-9, 1992.
22. Tuckey J., Bilateral compartment syndrome complicating prolonged lithotomy position, BR. J. ANNESTH., 77, 546-549, 1996.